Viper ULTRA Thrombolysis Catheter
一个 ultra infusion catheter specialized for direct thrombolytic delivery, featuring multi-hole design to uniformly distribute drugs across large clot segments.
"(《世界人权宣言》) Viper® Ultrasonic Pharmacomechanical Thrombolysis System 是一个 微创 device designed to dissolve thrombi by combining targeted ultrasonic waves with controlled tPA infusion. By thinning fibrin 和 increasing clot porosity, the system enables deeper drug penetration into the thrombus, thereby enhancing the efficacy of pharmacological therapy. This approach helps mitigate potential bleeding complications 和 preserves vessel integrity, offering a more refined, patient-centric strategy for acute thrombosis management.
Ultrasonic Wave Delivery
- Controlled Ultrasound: Low-power ultrasonic energy focuses on fibrin disruption, loosening the structural integrity of the clot.
- Enhanced Porosity: Breaking fibrin strands encourages tPA to penetrate deeper, ensuring thorough thrombus dissolution.
Pharmacomechanical Infusion
- tPA Administration: A site-specific delivery of tissue plasminogen activator (tPA) directly into the clot.
- Synergistic Effect: Ultrasonic micro-cavitation augments the fibrinolytic effect, requiring lower drug doses and potentially reducing hemorrhagic complications.
Gentle Mechanization
- Minimal Vessel Trauma: Ultrasonic waves are calibrated to avoid damaging valves, vessel walls, or critical structures within the venous or pulmonary vasculature.
- Reduced Bleeding Risk: Lower overall drug usage and localized infusion can curtail systemic side effects.
- Controlled Ultrasound: Low-power ultrasonic energy focuses on fibrin disruption, loosening the structural integrity of the clot.
- Enhanced Porosity: Breaking fibrin strands encourages tPA to penetrate deeper, ensuring thorough thrombus dissolution.
- tPA Administration: A site-specific delivery of tissue plasminogen activator (tPA) directly into the clot.
- Synergistic Effect: Ultrasonic micro-cavitation augments the fibrinolytic effect, requiring lower drug doses and potentially reducing hemorrhagic complications.
- Minimal Vessel Trauma: Ultrasonic waves are calibrated to avoid damaging valves, vessel walls, or critical structures within the venous or pulmonary vasculature.
- Reduced Bleeding Risk: Lower overall drug usage and localized infusion can curtail systemic side effects.
产品规格
规格 | 细节/价值 |
产品名称 | Viper ULTRA Thrombolysis Catheter |
预期用途 | Catheter-directed infusion of thrombolytics in acute or subacute thrombus (peripheral, venous, or arterial) |
导管设计 | Multi-hole distal segment for uniform drug dispersion, possible radiopaque marker at tip |
材料 | Pebax/Polyamide shaft, potentially braided or reinforced |
外径 (F) | ~4–6F (depending on infusion lumen capacity) |
工作长度 | ~80–150 cm (varies by product code) |
Infusion Ports | Distributed side ports over a defined segment for consistent thrombolytic delivery |
导丝兼容性 | Typically 0.014” or 0.018” |
无菌 | 无菌,一次性使用 |
保质期 | ~2–3 years if stored at 15–25 °C in sealed packaging |
临床适应症 | Thrombolytic infusion for DVT, peripheral arterial occlusions, possibly for intra-graft thrombosis |
禁忌症 | Highly calcified lesions, severe vessel tortuosity preventing safe passage, known device material allergies |
订购和尺寸表
外径 (F) | 工作长度(厘米) | Infusion Segment (cm) | 产品代码 | 说明 |
4F | 80 | 10 | VPR-4F-80-10 | Smaller OD for distal or small vessel usage |
4F | 120 | 15 | VPR-4F-120-15 | Longer shaft, moderate infusion segment |
5F | 80 | 10 | VPR-5F-80-10 | Slightly larger OD for heavier clot load |
5F | 120 | 20 | VPR-5F-120-20 | Extended length with longer infusion zone |
6F | 100 | 15 | VPR-6F-100-15 | Common size for multi-level peripheral lesions |
6F | 150 | 30 | VPR-6F-150-30 | Max length, extensive infusion segment |